<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03047655</url>
  </required_header>
  <id_info>
    <org_study_id>GesundLeben</org_study_id>
    <nct_id>NCT03047655</nct_id>
  </id_info>
  <brief_title>Effects of Short-term Interventions for a Healthy Lifestyle on the Human Lipidome in Subjects With Metabolic Syndrome</brief_title>
  <acronym>GesundLeben</acronym>
  <sponsors>
    <lead_sponsor>
      <agency>German Institute of Human Nutrition</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>German Institute of Human Nutrition</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      A growing number of cross-sectional studies is investigated the role of the human lipidome as
      a new biomarker for metabolic diseases. However, data on this issue is still sparse and
      especially interventional data is not available up to now.

      &quot;GesundLeben&quot; will provide data on 100 human subjects with metabolic syndrome, undergoing
      distinct types of lifestyle intervention for 6 weeks. Standardized metabolic assessment will
      be covered with routine laboratory parameters and oral glucose tolerance test as well as
      non-radiologic anthropometric measurements.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      A growing number of cross-sectional studies is investigated the role of the human lipidome as
      a new biomarker for metabolic diseases. However, data on this issue is still sparse and
      especially interventional data is not available up to now. We intend to clarify, if the human
      lipidome is correlating with metabolic state and if changes in this state reflect on the
      lipidome. Using high-throughput shot-gun technique, we will be able to measure several
      hundreds of lipid species in one blood sample.

      The &quot;GesundLeben&quot; trial will provide data on 100 human subjects with metabolic syndrome,
      undergoing distinct types of lifestyle intervention for 6 weeks. The cohort will be designed
      to include participants from both sexes, but be restricted on subjects without impaired
      glucose tolerance.

      Standardized metabolic assessment will be covered with routine laboratory parameters (e.g.
      transaminases, HbA1c) and oral glucose tolerance test as well as non-radiologic
      anthropometric measurements (BMI, WHR, BIA).
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 9, 2017</start_date>
  <completion_date type="Anticipated">December 2017</completion_date>
  <primary_completion_date type="Anticipated">August 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>change in lipidome pattern</measure>
    <time_frame>6 weeks</time_frame>
    <description>complex human lipidome (blood levels of several hundreds of lipid species) will be assessed before and after intervention</description>
  </primary_outcome>
  <primary_outcome>
    <measure>reduction of blood pressure</measure>
    <time_frame>6 weeks</time_frame>
    <description>systolic and diastolic blood pressure</description>
  </primary_outcome>
  <primary_outcome>
    <measure>NAFLD reduction</measure>
    <time_frame>6 weeks</time_frame>
    <description>NAFLD, estimated by fatty liver index (FLI)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>weight loss</measure>
    <time_frame>6 weeks</time_frame>
    <description>loss in body weight / BMI</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>reduction of insulin resistance</measure>
    <time_frame>6 weeks</time_frame>
    <description>assessed by oral glucose tolerance test, glucose and insulin levels; IS indices (Matsuda, IGI etc.)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>improvement in quality of life</measure>
    <time_frame>6 weeks</time_frame>
    <description>standardized questionnaires</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Metabolic Syndrome</condition>
  <condition>NAFLD</condition>
  <condition>Obesity</condition>
  <condition>Hypertension</condition>
  <arm_group>
    <arm_group_label>Physical activity only</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>pedometers have to be used throughout all days; daily amount of steps is reported via App or website; 10000 steps are defined as daily goal</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Physical activity + Dietary treatment</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>pedometers have to be used throughout all days; daily amount of steps is reported via App or website; 10000 steps are defined as daily goal
additionally, subjects will be provided with one healthy muffin per day (450 kcal; low GI, high load of PUFA and isomaltulose) over 6 weeks</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Lifestyle intervention (physical activity)</intervention_name>
    <description>Dietary treatment with or without additional motivation on more physical activity</description>
    <arm_group_label>Physical activity only</arm_group_label>
    <arm_group_label>Physical activity + Dietary treatment</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Lifestyle intervention (PUFA/isomaltulose-enriched muffin)</intervention_name>
    <arm_group_label>Physical activity + Dietary treatment</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  hypertension

          -  NAFLD

          -  obesity

          -  hyperuricemia

          -  dyslipoproteinemia

        Exclusion Criteria:

          -  prediabetes / overt diabetes mellitus

          -  present cancer

          -  systemic infection

          -  chronic inflammatory disease

          -  recent stroke / myocardial infarction (6 months)

          -  pregnancy

          -  addiction / severe psychiatric diseases
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Stefan Kabisch, Dr.med.</last_name>
    <phone>030 450 514 429</phone>
    <email>stefan.kabisch@dife.de</email>
  </overall_contact>
  <location>
    <facility>
      <name>German Institut for Human Nutrition; Department for Clinical Nutrition</name>
      <address>
        <city>Nuthetal</city>
        <state>Brandenburg</state>
        <zip>14458</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Margrit Kemper, Dr. med.</last_name>
      <phone>033200 88 2775</phone>
      <email>margrit.kemper@dife.de</email>
    </contact>
    <contact_backup>
      <last_name>Silke Hornemann</last_name>
      <phone>033200 88 2779</phone>
      <email>silke.hornemann@dife.de</email>
    </contact_backup>
    <investigator>
      <last_name>Margrit Kemper, Dr. med.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Silke Hornemann</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Christiana Gerbracht, Dr.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>DIfE (German Institute for Human Nutrition)</name>
      <address>
        <city>Berlin</city>
        <zip>12203</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Stefan Kabisch, Dr. med.</last_name>
      <phone>030 450 514 429</phone>
      <email>stefan.kabisch@dife.de</email>
    </contact>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>February 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 21, 2016</study_first_submitted>
  <study_first_submitted_qc>February 6, 2017</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 9, 2017</study_first_posted>
  <last_update_submitted>February 22, 2017</last_update_submitted>
  <last_update_submitted_qc>February 22, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">February 24, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>German Institute of Human Nutrition</investigator_affiliation>
    <investigator_full_name>Prof. Dr. med. Andreas F. H. Pfeiffer</investigator_full_name>
    <investigator_title>Director (Dpt. Clinical Nutrition)</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Syndrome</mesh_term>
    <mesh_term>Metabolic Syndrome X</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

